A study has found a temporary increase in shingles risk after the first dose of the Shingrix vaccine. The shingles vaccine is a topic of consideration for various groups, including people with cancer, those taking arthritis drugs, and older adults. The effectiveness and usage of the two-dose Shingrix vaccine are being examined, including its use in immunocompromised adults and its long-term protection.